However, transcriptomic data revealed no significant differences in the mRNA expression levels of PD-1 and PD-L1 or in immune cell infiltration between MMR-altered and MMR-wt breast cancers (Figure 3B,C). This evidence concerns the gene MRC1 and breast carcinoma.